The value of routine non-invasive tests to predict clinical outcome in stable angina

Area of Science:

• Cardiology
• Clinical Risk Prediction
• Internal Medicine

Background:

• Chronic stable angina presents variable risks for acute coronary events like myocardial infarction (MI).
• Accurate risk stratification is essential for optimizing patient management.
• Identifying predictors of adverse outcomes in stable angina is a clinical necessity.

Purpose of the Study:

• To identify clinical features and non-invasive test parameters associated with high risk of coronary events in stable angina patients.
• To develop a clinically useful model for predicting adverse outcomes in this population.

Main Methods:

• Analysis of 682 patients with stable angina and positive exercise tests from the TIBET study.
• Baseline assessments included resting ECG, exercise tolerance testing, and echocardiography off anti-anginal therapy.
• Patients were randomized to atenolol, nifedipine, or combination therapy, with follow-up for an average of 2 years.

Main Results:

• Prior MI or prior CABG were significant clinical predictors of adverse outcomes.
• ECG-identified left ventricular hypertrophy and echocardiogram-measured increased left ventricular dimensions predicted adverse events.
• Time to ischemia on exercise testing was also a key factor.

Conclusions:

• A predictive model combining clinical factors (prior MI/CABG), ECG (LVH), echocardiogram (LV dimensions), and exercise test (time to ischemia) can estimate 2-year event probability.
• This model offers a clinically applicable tool for risk stratification in stable angina patients.
• Improved risk prediction facilitates personalized management strategies for chronic stable angina.